Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAST: Typhoid Vaccine Efficacy in Human Challenge Model
NCT02324751Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Sep 2015
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of typhoid conjugate vaccine in typhoid fever, sponsored by University of Oxford. Started Sep 2015; status: completed.
02
Drugs
typhoid conjugate vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT02324751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02324751.